Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01340781 · ClinicalTrials.gov registry record

Screening Tools for Obstructive Sleep Apnea (OSA) in Hospitalized Medical Patients

A clinical trial of Obstructive Sleep Apnea, sponsored by MetroHealth Medical Center.

Completed
Registry status
110
Enrollment target
1
Study location

NCT01340781 is a study of Obstructive Sleep Apnea that has completed, run by MetroHealth Medical Center. The registered enrollment target is 110 participants, below the 221-participant average among 155 other Obstructive Sleep Apnea trials with a reported enrollment target (50% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01340781, a study of Obstructive Sleep Apnea, has completed, sponsored by MetroHealth Medical Center.

COMPLETED
Registry status
110 participants
Enrollment target
1
Study location

Study Summary

The prevalence of obstructive sleep apnea (OSA) in patients admitted to the hospital is likely significantly higher than the general population as hospitalized patients carry a high prevalence of co-morbid conditions, such as diabetes and cardiovascular diseases, that are commonly associated with OSA. The true prevalence of OSA in hospitalized patients is not known, though there is limited data suggesting that the rate of OSA in hospitalized patients is indeed high. Two studies have reported on the rate of polysomnographic (PSG) diagnosis of OSA in patients referred for OSA evaluation while in-hospital. These studies reported frequencies of 77% (in a retrospective study of 100 patients) and 88-100% (in an observational study of 250 patients). Similarly, 2 studies evaluated the prevalence of sleep disordered breathing in patients admitted with acutely decompensated heart failure, finding frequencies of sleep apnea in 97% (prospective study of 29 patients studied with PSG) and 75% (prospective study of 395 consecutive patients studied with portable monitors). However, all of these studies are limited by either study design (retrospective), small numbers, limited channel portable monitoring, or evaluations of highly select patient populations. Furthermore, none of these studies examined screening tools that may help to identify which patients are at risk for OSA and thus might require the more extensive and expensive objective testing. This study will test the following hypotheses: 1. The prevalence of OSA in unselected hospitalized medical patients will be more than 50% of the study population. Specific Aim 1: To determine the prevalence of OSA in a group of unselected hospitalized medical patients by a combination of sleep symptoms and PSG performed while in-hospital. 2. Screening tools will be able to accurately identify OSA in hospitalized medical patients. Specific Aim 2: To determine the accuracy of different screening questionnaires for the diagnosis of O

Conditions Studied

Interventions

  • PROCEDURE Polysomnogram

Study Locations (1)

Ohio

  • MetroHealth Medical Center - Cleveland

Trial Details

FieldValue
Enrollment Target 110 participants
Start Date 2012-02
Est. Completion 2013-02

Sponsor

MetroHealth Medical Center

76 total trials

What the Registry Record Tells You About NCT01340781

The ClinicalTrials.gov registry entry for NCT01340781 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 110 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 221-participant average among 155 other Obstructive Sleep Apnea trials with a reported enrollment target (50% lower). The listed sponsor is MetroHealth Medical Center, which has 76 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Obstructive Sleep Apnea appearing as the primary indexed condition, and to 1 intervention - of which Polysomnogram is the first listed.

NCT01340781 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT01340781 about?

NCT01340781 is a clinical study titled "Screening Tools for Obstructive Sleep Apnea (OSA) in Hospitalized Medical Patients". The prevalence of obstructive sleep apnea (OSA) in patients admitted to the hospital is likely significantly higher than the general population as hospitalized patients carry a high prevalence of co-morbid conditions, such as diabetes and cardiovascular diseases, that are commonly associated with OS...

What is the current status of trial NCT01340781?

This trial is currently completed. The enrollment target is 110 participants. The study started on 2012-02. Estimated completion is 2013-02.

What conditions does trial NCT01340781 study?

This clinical trial studies the following conditions: Obstructive Sleep Apnea.

What interventions are being tested in trial NCT01340781?

The interventions under investigation include: Polysomnogram (PROCEDURE).

Who is sponsoring clinical trial NCT01340781?

This trial is sponsored by MetroHealth Medical Center, which has 76 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01340781 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obstructive Sleep Apnea

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.